The Najoua Mlika-Cabanne Innovation Award is named in memory of, formerly Deputy Head of the Guidelines Department at the Haute Autorité de Santé (HAS, French National Authority for Health), Trustee of the Guidelines International Network between 2003 and 2010, and G-I-N Honorary Patron.
Najoua Mlika-Cabanne graduated in medicine from Sousse Medical Faculty in Tunisia in 1982. From a local government post in public health in Tunisia, Najoua moved to clinical research in France first at the Gustave Roussy Cancer Centre and then at INSERM, the French National Institute for Health and Medical Research. After that Najoua became deputy head of the Guidelines Department at the Haute Autorité de Santé (HAS, French National Authority for Health). She was in charge of various aspects of the development of clinical practice guidelines for over 10 years: drafting of guidelines, managing a team of guideline developers, and university teaching, in particular courses on medical statistics, quality management, and assessment of health systems. In her post at HAS, she liaised with experts in a very wide variety of aspects of the development of quality of care and health technology assessment.
From 2000, Najoua was increasingly involved in national and international partnerships. She was on the Committee for the Assessment of National Registers at the French Institute for Public Health Surveillance (InVS), was the mandated HAS representative for several collaborative international projects (for example, CoCanCPG), and was an active member of the International Review Panel of the International Society for Quality in Healthcare (ISQUA), the ADAPTE collaboration, and G-I-N.
Najoua was elected to the G-I-N Board in 2003 and was co-chair of the international Working Group on Evidence Tables. She was also a co-editor of enGINe, the G-I-N newsletter.
During her career Dr Najoua Mlika-Cabanne made a significant contribution to the science of clinical guideline development and consistently fostered international collaboration and friendship.
Information about the award
Nomination and Selection Process
Nominations can only be made by organisational and individual G-I-N members.
Self-nomination is not allowed.
An Award Committee comprised of guideline experts is selected by the Board of Trustees. The Award Committee is comprised of up to 7 members including a chair, a Board liaison, and a geographically diverse representation of G-I-N guideline experts. The Award Committee set and apply selection criteria to select a nominee, however the final decision is made by the Board of Trustees.
The individual has put forth extraordinary efforts on innovation in the methodology, development, and /or implementation of clinical practice guidelines.
The individual has provided an extraordinary (outstanding) contribution to the guideline community.
Current members of the Board or G-I-N staff are not eligible.
Current members of the Award Committee are not eligible.
Nominees are required to be G-I-N members. Shortlisted nominees will be re-considered for up to two years.
Nominations now open for the 2017 award
Nominations should include:
- A statement of no more than 500 words, giving reasons for the nomination and stating why the nominee deserves the award
- Name, position, affiliation and contact details of the nominee
- CV or link to the CV and list of relevant publications of the nominee
- Name, position, affiliation and contact details of the person(s) sending the nomination
In addition to the award, the successful award recipient will also receive complimentary registration for the Global Evidence Summit in Cape Town, economy travel to the summit plus 3 nights’ accommodation.
Nominations should be sent by email to the G-I-N office: firstname.lastname@example.org no later than Thursday 19th January 2017.
Fourth award 2016
Richard Rosenfeld, MD, MPH was announced as a recipient of the fourth Najoua Mlika-Cabanne award by Ina Kopp, G-I-N Chair 2014 - 16 during the opening ceremony of the thirteenth G-I-N Conference in Philadelphia.
Dr Rosenfeld has been the innovator and driving force behind the CPG program at the America Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF), including lead author of the AAO-HNSF Guideline Development Manual on Clinical Practice Guidelines We Can Trust. Dr Rosenfeld has authored and/or co-authored 18 CPG’s and given over 100 presentations, including podcasts on CPGs, their development, dissemination and implementation both nationally and internationally.
In 2011, Dr Rosenfeld served as Chair of the G-I-N Scientific Committee and initiated the establishment of the G-I-N North American Community (G-I-N/NA) at the G-I-N Annual meeting in South Korea, ultimately serving as the community’s first chair 2012/13. In 2015, he was awarded the G-I-N/NA Outstanding Leadership Award in recognition of his contribution to the guideline movement. Dr Rosenfeld conceived the E-GAPPS (Evidence-based Guidelines Affecting Policy Practice and Stakeholders) conference, sponsored by G-I-N/NA and the New York Academy of Medicine, and served as conference co-chair in 2013 and 2015. Today he serves as chair emeritus on the G-I-N/NA Steering Group.
Dr Rosenfeld was a member of the G-I-N Board of Trustees from 2011to 2014 and served as Editor for G-I-N’s enGINe from 2012-2014.
In collaboration with Richard N. Shiffman, MD, Dr Rosenfeld assisted in developing BRIDGE-Wiz (Buidling Recommendations In a Developer’s Guidelines Editor), which uses a software wizard approach to ensure CPG recommendations are clear, actionable and implementable.
Dr Rosenfeld is one of the earliest champions for fully engaging consumers in developing CPGs and ensuring that CPG s include tools and resources for consumers to enhance uptake and implementation. He is on the advisory board for Consumers United for Evidence-based Healthcare (CUE) and prepared an on-line instructional video Serving on a Clinical Practice Guideline Panel for Consumers that has been instrumental in linking G-I-N and CUE. This linkage subsequently resulted in the adoption of consumers on CPG development panels by organisations developing CPGs.
Dr Rosenfeld continues to move the AAO-HNSF forward, most recently as chair of the AAO-HNS Performance Measures Task Force, which will lead the AAO-HNSF efforts for quality measures that will advance the implementation of and adherence to published CPGs.
Dr Ilkka Kunnamo was presented with the fourth Najoua Mlika-Cabanne award by Ina Kopp, G-I-N Chair 2014 - 16 during the opening ceremony of G-I-N 2016 in Philadelphia.
Dr Kunnamo is currently a practising GP at Karstula Health Centre, Karstula, Finland as well as Adjunct Professor of General Practice, University of Helsinki, Finland. Additionally, he has the role of Editor-in-Chief, EBM Guidelines, Duodecim Medical Publications Ltd and EBMeDS, Duodecim Medical Publications Ltd, Helsinki, Finland.
Dr Kunnamo was the founder of the Finnish electronic evidence based medicine database called “Lääkärin Käsikirja”, which was launched in the 1990’s, and is currently used daily by almost all Finnish health care organisations and professionals. The database has been translated into 9 languages.
Dr Kunnamo was one of the leading persons in the early days of the Finnish programme which produced comprehensive national clinical practice guidelines (Current Care Guidelines). Today, altogether 101 updated Current Care Guidelines are in use, and are held in high esteem by the professionals as well as by the authorities in Finland.
Dr Kunnamo is the founder and current Editor-in-Chief of the Evidence-Based Medicine Electronic Decision Support service (EBMeDS), that integrates electronic health record systems with the evidence-based clinical practice guidelines. EBMeDS is revolutionary with its simple and logic IT-architecture, since its usage is not dependent on a specific EHR-solution, but can be integrated with various IT-solutions globally. Thus, the EBMeDS offers a valuable tool for implementation of the CPG’s both in Finland and globally.
Dr Kunnamo has been involved with G-I-N from its early days. He is a founding member of G-I-N’s Implementation as well as Multimorbidity working groups.
Dr Kunnamo is highly appreciated by his coworkers for his innovative and encouraging attitude.
Third Award 2015
Second award 2014
First award 2012